Figure 2From: Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis Enrollment of patients. HCC: hepatocellular carcinoma; RT: radiotherapy; PVTT: portal vein tumor thrombosis; HVTT: hepatic vein tumor thrombosis.Back to article page